We identified one druggable molecular circuitry, based on IL-6/Signal Transducer and Activator of Transcription 3 (STAT3) axis that could be exploited to increase drug permeability across BBB, improving the delivery of chemotherapeutic drugs to GBM. The gene discussed is IL6; the disease is glioblastoma.